Thank you for your interest in clinical trials for Mycosis FungoidesPlease click "Search" to find Mycosis Fungoides clinical trials and medical research studies.If you receive too many study listings you may enter your zip code to find the locations closest to you.
Your search returned no results. Get alerts when studies become available.
Your search returned 13 studies. (Get alerts for new studies):T Cell Repertoire Analysis of Immune Mediated Skin DiseasesConditions: Psoriasis - Mycosis Fungoides1 Location availableBlood and Tissue Collection for Cutaneous Lymphoma ResearchConditions: Cutaneous T-Cell Lymphoma - Sezary Syndrome - Mycosis Fungoides1 Location availableGemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary SyndromeConditions: Lymphoma1 Location availableVorinostat in Patients With Primary Cutaneous T-Cell LymphomaConditions: Stage I Cutaneous T-cell Non-Hodgkin Lymphoma - Stage I Mycosis Fungoides/Sezary Syndrome - Stage II Cutaneous T-cell Non-Hodgkin Lymphoma - Stage II Mycosis Fungoides/Sezary Syndrome - Stage III Cutaneous T-cell Non-Hodgkin Lymphoma - Stage III Mycosis F1 Location availablePralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaConditions: Cutaneous T-cell Lymphoma - Mycosis Fungoides - Sezary Syndrome - Primary Cutaneous Anaplastic Large Cell Lymphoma3 Locations availableLow-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis FungoidesConditions: Cutaneous Lymphoma3 Locations availableStudy of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary SyndromeConditions: Mycosis Fungoides - Sezary Syndrome6 Locations availableA-dmDT390-bisFv (UCHT1) Immunotoxin Therapy for Patients With T-cell DiseasesConditions: T-cell Lymphomas - T-cell Leukemia - Sezary Syndrome - Mycosis Fungoides1 Location availablePEG-Interferon Alfa-2b and Ultraviolet Light Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Mycosis Fungoides/Sezary SyConditions: Lymphoma1 Location availableA Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Conditions: Primary Cutaneous Anaplastic Large Cell Lymphoma, - Mycosis Fungoides1 Location availableAlemtuzumab Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Mycosis Fungoides/Sezary SyndromeConditions: Lymphoma1 Location availableSGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)Conditions: CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma - Lymphoma, Primary Cutaneous Anaplastic Large Cell - Lymphomatoid Papulosis - Mycosis Fungoides - Skin Lymphoma - Cutaneous Lymphomas - Lymphoma - Hematologic Disorder1 Location availableTopical Romidepsin to Treat Early-Stage Cutaneous T-Cell LymphomaConditions: Mycosis Fungoides - Cutaneous T-Cell Lymphoma - Neoplasms1 Location available
Didn't find what you were looking for? Try these alternatives: